Jun Teisima

10PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsRadiation therapySensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 27, 2026
Comparison of effectiveness and safety of pembrolizumab plus lenvatinib versus nivolumab plus cabozantinib for metastatic renal cell carcinoma: a real-world study.

|Jul 14, 2025
Risk stratification for recurrence after nephrectomy in high-risk renal cell carcinoma patients.

Taisuke Tobe, Jun Teishima, Hideto Ueki

|Sep 19, 2022
Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma.

Yohei Sekino, Jun Teishima, Gangning Liang

|Aug 11, 2022
Prognostic differences among Grade Group 4 subgroups in robotic-assisted radical prostatectomy.

Takeshi Sasaki, Shin Ebara, Tomoyuki Tatenuma

|Jun 16, 2022
Robot-assisted partial nephrectomy with minimum follow-up of 5 years: A multi-center prospective study in Japan.

Junya Furukawa, Nobuyuki Hinata, Jun Teisima

|Jul 06, 2021
Tumor contact length of prostate cancer determined by a three-dimensional method on multiparametric magnetic resonance imaging predicts extraprostatic extension and biochemical recurrence.

Shunsuke Miyamoto, Keisuke Goto, Yukiko Honda

Pageof 2

Frequent Collaborators

3 joint publications

Shogo Inoue

2 joint publications

Nobuyuki Hinata

1 joint publications

Yuki Kohada

1 joint publications

Kenichiro Fukuoka